<DOC>
	<DOCNO>NCT01816529</DOCNO>
	<brief_summary>The goal study determine potential Diltiazem Hydrochloride 2 % Cream induce sensitization repeat topical application skin healthy subject control condition .</brief_summary>
	<brief_title>Topical Safety Study Topical Diltiazem Hydrochloride</brief_title>
	<detailed_description>The primary objective study determine potential Diltiazem Hydrochloride 2 % Cream vehicle induce sensitization repeat topical application skin healthy subject control condition . In addition , irritation potential investigational product assess Induction Phase safety assess evaluation adverse event ( AEs ) report study .</detailed_description>
	<mesh_term>Diltiazem</mesh_term>
	<criteria>Are healthy male female ( confirm medical history ) ; Are 18 year age old ; In case female childbearing potential , use acceptable form birth control ( oral/implant/injectable/transdermal contraceptive , intrauterine device , condom spermicide , diaphragm spermicide , abstinence , partner 's vasectomy ) . Abstinence vasectomy acceptable female subject agree implement one acceptable method birth control lifestyle/partner change ; In case female childbearing potential : negative urine pregnancy test ( UPT ) Screening , willing submit pregnancy test end study ( EOS ) ; Are free systemic dermatologic disorder , , opinion investigator , interfere study result increase risk adverse event ; Are skin type race , provide skin pigmentation allow discernment erythema ; Read , understand , provide sign informed consent . Have sick sinus syndrome except presence function ventricular pacemaker ( confirm via medical history ) ; Have secondor thirddegree AV block except presence function ventricular pacemaker ( confirm via medical history ) ; Have hypotension ( le 90 mm Hg systolic , determine perform vital sign ) ; Have acute myocardial infarction pulmonary congestion document xray ( confirm via medical history ) ; Have visible skin disease application site , opinion investigative personnel , interfere evaluation test site reaction ; Are willing refrain use topical/systemic analgesic aspirin ( daily use 81 mg aspirin acceptable ) , Aleve , Motrin , Advil , Nuprin 72 hour prior study ( occasional use acetaminophen permit ) ; Are use systemic/topical corticosteroid 3 week prior study , systemic/topical antihistamine 72 hour prior study ; Are use medication , opinion investigative personnel , interfere study result , include antiinflammatory medication ; Are unwilling unable refrain use sunscreen , cosmetic , cream , ointment , lotion , similar product back study ; Have psoriasis and/or active atopic dermatitis/eczema ; Are females pregnant , plan become pregnant study , breastfeed child ; Have know sensitivity constituent present material evaluate ; Have damage skin around test site , include sunburn , excessively deep tan , uneven skin tone , tattoo , scar , excessive hair , numerous freckle , disfiguration test site ; Have receive treatment type internal cancer within 5 year prior study entry ; Have history , currently treat skin cancer ; Are currently participate clinical testing , Have know sensitivity adhesive ; and/or Have receive investigational treatment ( ) within 4 week prior study entry .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>